Novo Nordisk is paying Valo Health $60 million up front to gain three preclinical cardiovascular disease programs. Milestone payments for those programs and others covered under the artificial intelligence drug discovery pact could reach up to $2.7 billion.

Specific targets were not disclosed, but Merck KGaA is betting the artificial intelligence technologies of Exscientia and BenevolentAI will discover into new drugs for cancer, neurology, and immunology.

By making large amounts of diverse data widely available, healthcare institutions can feel confident about the evaluation, creation, and validation of algorithms as they’re transitioned from ideation to use.

By revealing how tumors interact with immune cells, Noetik aims to identify new targets for new cancer drugs. The startup and its artificial intelligence-driven platform are supported by $14 million in seed financing.

Do some people simply think the A in AI stands for Automation? Most likely the confusion is due to a lack of understanding of what AI truly is, combined with a strong desire to use the term for marketing purposes.

Biotech startups raised $2.6 billion globally in the second quarter of this year, but that’s down nearly 46% compared to the same period last year, according to a report from Pitchbook. Capital is harder to find, and the report projects an uptick in M&A activity as companies run out of cash.

UltraSight, based in Israel, recently received a nod from the FDA to market its UltraSight AI Guidance product that can assist medical professionals without sonography experience in acquiring cardiac ultrasound images and allow for more widespread detection of heart diseases.

Allurion Technologies has commercialized a gastric balloon in the form of a pill that patients swallow. But the weight loss platform from the now NYSE-listed company also includes AI-driven software that provides insights about a patient’s progress, technology with the potential for use alongside obesity drugs.

A schizophrenia drug candidate from partners Sumitomo Pharma and Otsuka Pharmaceutical failed to outperform a placebo in two Phase 3 studies. The compound is the most advanced program from a psychiatry and neurology collaboration spanning four drugs discovered by an artificial intelligence technology platform.

Nvidia’s investment isn’t just working capital for Recursion Pharmaceuticals’ technology-driven drug discovery research. Recursion says it will get more computing power as well as the possibility of joining forces with Nvidia in research.

There are three key areas of the healthcare sector where generative AI is booming the most — in terms of both venture capital funding and the development of innovative technology — according to Anjalika Komatireddy, an analyst at CB Insights. During a recent webinar, she discussed the generative AI activity occurring in these three areas: care delivery and navigation, digital therapeutics and drug discovery.

With few workers entering a field dominated by older Gen X-ers and Baby Boomers, there’s a growing gap in skilled medical coders — people who read notes from doctors and apply appropriate codes for billing and reimbursement purposes. So many are turning to AI.

Eyenuk recently received FDA clearance to use the Topcon NW400 retinal camera with its EyeArt AI system, which automatically detects diabetic retinopathy. The company said this FDA clearance makes its system the only AI system that is FDA-cleared for use with multiple retinal cameras produced by different manufacturers.

Losing sight of organizational goals and priorities and operating without a clear, supported plan can lead to a scatter-shot approach to AI investment that may duplicate investments, misallocate resources, and cause stakeholders to become cynical about AI’s value and potential.

The use of LLMs in healthcare is still incredibly nascent, so many experts are calling for a safety framework to make this uncharted territory feel safer. There are still a lot of unknowns, but avoiding clinical use cases and not inputting patients’ health information seem to be the most important guardrails providers are putting around LLMs at the moment.

At a time when the vast majority of people are just beginning to hear and learn about artificial intelligence, it is critical that technology executives make a concerted effort to reinforce its purpose and intent.

There are too many flaws in AI for it to replace physicians, execs said during a Monday panel at the MedCity INVEST conference in Chicago. Instead, it should be used to make physicians’ work easier.

Suki recently announced one of its biggest partnerships to date: it is integrating its voice assistant into Epic’s EHR. The startup’s assistant can be thought of as like Apple’s Siri or Amazon’s Alexa — but for doctors.

Recursion Pharmaceuticals is acquiring two Canada-based artificial intelligence startups, Cyclica and Valence. The “biology-first company” says both deals build up its capability to apply AI to the chemistry side of drug discovery.

Season 2 of our MedCity Pivot Podcast launches today with a conversation about how AI can be leveraged to transform precision medicine.

MedCity News connected with Integra Connect’s COO, Cory Wiegert at ViVE 2023 to discuss how their new platform will go beyond the “one size fits all” approach to data curation.

With AI being so new, there are some best practices for companies to follow when bringing it into healthcare. This includes partnerships and understanding the shortcomings of AI, several experts said during a session at the HIMSS 2023 conference.

Recently, scientists shared new findings that may indicate the inner core of the earth has […]

Nvidia and Medtronic recently announced a collaboration focused on embedding AI into medical devices. The two companies plan to create marketplace for AI applications that will allow developers and clinicians to develop their own algorithms to use on Medtronic’s medical devices.

Virtual care company TytoCare has received FDA clearance for its wheeze detection algorithm, allowing the company to begin commercializing the product in the U.S. The new algorithm is an expansion of Tyto Insights, the company’s AI-powered diagnosis support software.

The healthcare industry is one sector that can never grow stagnant. It’s constantly being inundated […]

One healthcare AI expert thinks ChatGPT could have dangerous implications for the field if it’s not used with the proper context. People already turn to sources like Reddit and TikTok when they have a question about a medical concern they’re experiencing — Americans putting too much trust in ChatGPT to answer these questions could make this phenomenon a much bigger problem.

Abridge announced the largest deployment of its technology to date — the University of Kansas Health System will adopt the software for more than 1,500 of its physicians across 140 locations. The startup’s technology listens to visits and creates a near-instant summary that adheres to physicians’ prototypical note structure.